SCHEMBL5692156

SCHEMBL5692156

CC(C)(C)c1cc(CC[Si](c2ccccc2)(C(C)(C)C)C(C)(C)C)cc(C(C)(C)C)c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 7/20 0.47
KMT2A Q03164 5/20 0.47
MEN1 O00255 4/20 0.47
ALDH1A1 P00352 5/20 0.41
LMNA P02545 3/20 0.41
TSHR P16473 3/20 0.41
HTT P42858 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
AGTR1 P30556 1/20 0.41
MAPK1 P28482 3/20 0.41
GSR P00390 2/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
BLM P54132 2/20 0.41
ATM Q13315 2/20 0.41
HIF1A Q16665 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7530152 0.84 GAA (0.48) GAAKMT2AMEN1ALDH1A1LMNA
SCHEMBL5692085 0.84 GAA (0.48) GAAKMT2AMEN1ALDH1A1LMNA
SCHEMBL9007329 0.82 GAA (0.34) GAAKMT2AMEN1ALDH1A1LMNA
SCHEMBL9855739 0.77 GAA (0.57) GAAKMT2AMEN1ALDH1A1LMNA
SCHEMBL7522276 0.77 ALOX15 (0.42) GAAKMT2AMEN1ALDH1A1LMNA
SCHEMBL5693112 0.76 ALDH1A1 (0.50) GAAKMT2AMEN1ALDH1A1LMNA
SCHEMBL8389493 0.75 HPN (0.44) GAAKMT2AMEN1ALDH1A1LMNA
SCHEMBL7516736 0.75 ALDH1A1 (0.33) GAAKMT2AMEN1ALDH1A1TSHR
SCHEMBL11578296 0.74 GAA (0.54) GAAKMT2AMEN1ALDH1A1LMNA
SCHEMBL5693103 0.74 ALDH1A1 (0.52) GAAKMT2AMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1468692-B1 Use of 2,6-di-alkyl-4-silyl-phenols for treating xanthoma MERRELL PHARMA INC (US) 2006-04-26 EP disclosed
EP-0732928-B1 METHOD OF LOWERING SERUM CHOLESTEROL LEVELS WITH 2,6-DI-ALKYL-4-SILYL-PHENOLS MERRELL PHARMA INC (US) 2004-12-22 EP disclosed
EP-1468692-A2 Use of 2,6-di-alkyl-4-silyl-phenols for treating xanthoma MERRELL PHARMACEUTICALS INC. (US) 2004-10-20 EP disclosed
EP-1468693-A2 Use of 2,6-di -alkyl-4-silyl-phenols for treating diabetes mellitus MERRELL PHARMACEUTICALS INC. (US) 2004-10-20 EP disclosed
US-5795876-A ANTIINFLAMMATORY AGENTS HOECHST MARION ROUSSSEL, INC. (US) 1998-08-18 US disclosed
US-5532400-A 2,6-di-alkyl-4-silyl-phenols as antiatheroscelerotic agents MERRELL PHARMACEUTICALS INC. (US) 1996-07-02 US disclosed
EP-0464852-B1 Novel 2,6-di-alkyl-4-silyl-phenols as antiatherosclerotic agents and as antioxidants MERRELL DOW PHARMA (US) 1996-03-20 EP disclosed
US-5155250-A 2,6-DI-ALKYL-4-SILYL-PHENOLS AS ANTIATHEROSCEROTIC AGENTS MERRELL DOW PHARMACEUTICALS INC. (US) 1992-10-13 US disclosed
EP-0464852-A1 Novel 2,6-di-alkyl-4-silyl-phenols as antiatherosclerotic agents and as antioxidants MERRELL PHARMACEUTICALS INC. (US) 1992-01-08 EP disclosed